ES3067458T3 - Markers of endometrial cancer - Google Patents

Markers of endometrial cancer

Info

Publication number
ES3067458T3
ES3067458T3 ES23150361T ES23150361T ES3067458T3 ES 3067458 T3 ES3067458 T3 ES 3067458T3 ES 23150361 T ES23150361 T ES 23150361T ES 23150361 T ES23150361 T ES 23150361T ES 3067458 T3 ES3067458 T3 ES 3067458T3
Authority
ES
Spain
Prior art keywords
level
protein
endometrial carcinoma
clic1
subject
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES23150361T
Other languages
English (en)
Spanish (es)
Inventor
Garcia Elena Martinez
Ortega Eva Colas
Moreno Antonio Gil
Puigjaner Jaume Reventos
Bruno Domon
Antoine Lesur
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fundació Institut de Recerca Hospital Universitari Vall d'Hebron
Original Assignee
Fundació Institut de Recerca Hospital Universitari Vall d'Hebron
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fundació Institut de Recerca Hospital Universitari Vall d'Hebron filed Critical Fundació Institut de Recerca Hospital Universitari Vall d'Hebron
Application granted granted Critical
Publication of ES3067458T3 publication Critical patent/ES3067458T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/5755—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the uterine cervix, uterine corpus or endometrium
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/902—Oxidoreductases (1.)
    • G01N2333/908—Oxidoreductases (1.) acting on hydrogen peroxide as acceptor (1.11)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
    • G01N2333/95—Proteinases, i.e. endopeptidases (3.4.21-3.4.99)
    • G01N2333/964—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue
    • G01N2333/96425—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals
    • G01N2333/96427—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general
    • G01N2333/9643—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general with EC number
    • G01N2333/96486—Metalloendopeptidases (3.4.24)
    • G01N2333/96491—Metalloendopeptidases (3.4.24) with definite EC number
    • G01N2333/96494—Matrix metalloproteases, e. g. 3.4.24.7
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Reproductive Health (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
ES23150361T 2016-05-04 2017-03-30 Markers of endometrial cancer Active ES3067458T3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP16168328 2016-05-04

Publications (1)

Publication Number Publication Date
ES3067458T3 true ES3067458T3 (en) 2026-05-22

Family

ID=56096908

Family Applications (2)

Application Number Title Priority Date Filing Date
ES23150361T Active ES3067458T3 (en) 2016-05-04 2017-03-30 Markers of endometrial cancer
ES17713973T Active ES2974307T3 (es) 2016-05-04 2017-03-30 PERM como marcador de cáncer de endometrio

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES17713973T Active ES2974307T3 (es) 2016-05-04 2017-03-30 PERM como marcador de cáncer de endometrio

Country Status (11)

Country Link
US (2) US20190137499A1 (enExample)
EP (3) EP4180814B1 (enExample)
JP (3) JP7240712B2 (enExample)
AU (3) AU2017260806B9 (enExample)
CA (2) CA3022586A1 (enExample)
DK (1) DK3452829T3 (enExample)
ES (2) ES3067458T3 (enExample)
FI (1) FI3452829T3 (enExample)
PL (1) PL3452829T3 (enExample)
PT (1) PT3452829T (enExample)
WO (1) WO2017190896A1 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL3655778T3 (pl) * 2017-07-21 2023-09-18 Fundació Hospital Universitari Vall D'hebron - Institut De Recerca Agryna jako marker raka endometrium
AU2022315559A1 (en) * 2021-07-23 2024-02-15 Fundació Hospital Universitari Vall D'hebron - Institut De Recerca Biomarkers for endometrial cancer
CN113493838B (zh) * 2021-09-06 2021-11-23 北京泱深生物信息技术有限公司 子宫内膜癌相关的标志分子及其在诊断子宫内膜癌中的应用
KR102640230B1 (ko) * 2021-09-24 2024-02-22 가천대학교 산학협력단 C-peptide를 처리한 자궁내막 기질세포의 이동성 변화 기작을 이용한 자궁내막 관련질환의 진단 방법 및 자궁내막 관련질환 치료제의 스크리닝 방법

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4444879A (en) * 1981-01-29 1984-04-24 Science Research Center, Inc. Immunoassay with article having support film and immunological counterpart of analyte
AUPO573697A0 (en) * 1997-03-20 1997-04-10 Prince Henry's Institute Of Medical Research Diagnosis of endometrial cancer
DE602004028513D1 (de) * 2003-12-23 2010-09-16 Mount Sinai Hospital Corp Verfahren zum nachweis von mit endometrialer krankheit oder phase assoziierten markern
WO2008003024A2 (en) 2006-06-28 2008-01-03 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Method and composition for diagnosing endometrial cancer
EP2087152B1 (en) * 2006-10-27 2015-03-11 Walfish, Paul Endometrial biomarkers
CN105132529A (zh) 2009-07-24 2015-12-09 吉第克生物技术有限公司 子宫内膜癌的标记物

Also Published As

Publication number Publication date
EP4180814C0 (en) 2026-03-04
CA3022586A1 (en) 2017-11-09
JP2019516104A (ja) 2019-06-13
JP7797770B2 (ja) 2026-01-14
ES2974307T3 (es) 2024-06-26
EP4610655A2 (en) 2025-09-03
AU2023210591A1 (en) 2023-08-24
AU2017260806B2 (en) 2023-06-15
JP2024116127A (ja) 2024-08-27
US20190137499A1 (en) 2019-05-09
JP2023040246A (ja) 2023-03-22
FI3452829T3 (fi) 2024-03-20
WO2017190896A1 (en) 2017-11-09
PT3452829T (pt) 2024-03-22
BR112018072498A2 (pt) 2019-03-12
DK3452829T3 (da) 2024-03-25
AU2023210591B2 (en) 2025-06-26
AU2017260806A1 (en) 2018-12-13
AU2023210591B9 (en) 2025-07-10
EP4180814A2 (en) 2023-05-17
EP3452829B1 (en) 2024-01-24
AU2017260806B9 (en) 2023-07-20
EP3452829A1 (en) 2019-03-13
JP7492287B2 (ja) 2024-05-29
EP4180814B1 (en) 2026-03-04
CA3286798A1 (en) 2025-10-30
US20230221323A1 (en) 2023-07-13
EP4610655A3 (en) 2025-12-10
JP7240712B2 (ja) 2023-03-16
AU2025223935A1 (en) 2025-09-18
EP4180814A3 (en) 2023-07-12
PL3452829T3 (pl) 2024-05-20